Department of Gastroenterology, Cancer Institute Hospital, Tokyo, Japan,
Division of Gastroenterology and Hepatology, Toho University Omori Medical Center, Tokyo, Japan,
Digestion. 2021;102(6):938-945. doi: 10.1159/000517970. Epub 2021 Aug 17.
Curative rates of endoscopic treatment for undifferentiated-type early gastric cancer (EGC), particularly mixed poorly differentiated adenocarcinoma (MIXED-POR), are lower than those of endoscopic treatment for the differentiated type. Magnifying endoscopy with narrow-band imaging (ME-NBI) is useful for diagnoses of the histological type. This study aimed to investigate the detection rates of MIXED-POR among undifferentiated-type EGCs using biopsy and ME-NBI in order to improve curative rates through endoscopic treatment.
We analyzed 267 lesions initially subjected to endoscopic submucosal resection (ESD) and histologically diagnosed as undifferentiated-type EGCs between July 2005 and December 2016 at our hospital. We obtained written informed consent from all participants. Biopsy and ME-NBI findings were compared to distinguish pure signet ring cell carcinoma (PURE-SIG) and MIXED-POR. ME-NBI findings were divided into 2 categories depending on the presence of irregular vessels. Results of biopsy and ME-NBI (combination method) were also analyzed, and detection rates of MIXED-POR and PURE-SIG were evaluated in terms of sensitivity, specificity, and accuracy.
Overall, 114 lesions were analyzed. Fifty-eight lesions (50.9%) were identified as MIXED-POR. With biopsy, the detection rate of MIXED-POR was significantly lower than that of PURE-SIG (p < 0.0001). ME-NBI detected significantly more MIXED-POR with irregular vessels than PURE-SIG (p < 0.0001). The combination method could detect significantly more MIXED-POR than PURE-SIG (p < 0.0001). The sensitivity and accuracy for MIXED-POR diagnosis were significantly higher with the combination method than with biopsy alone (p < 0.0001).
DISCUSSION/CONCLUSION: Combining biopsy and ME-NBI improved the accuracy of pretreatment diagnosis before ESD in undifferentiated-type cancer.
内镜治疗未分化型早期胃癌(EGC),尤其是混合低分化腺癌(MIXED-POR)的治愈率低于分化型。窄带成像放大内镜(ME-NBI)有助于诊断组织学类型。本研究旨在通过内镜治疗提高治愈率,探讨活检和 ME-NBI 对未分化型 EGC 中 MIXED-POR 的检出率。
我们分析了 2005 年 7 月至 2016 年 12 月在我院接受内镜黏膜下剥离术(ESD)治疗并组织学诊断为未分化型 EGC 的 267 处病变。所有参与者均签署了书面知情同意书。比较活检和 ME-NBI 的发现以区分纯印戒细胞癌(PURE-SIG)和 MIXED-POR。根据不规则血管的存在,ME-NBI 结果分为 2 类。还分析了活检和 ME-NBI(联合方法)的结果,并根据敏感性、特异性和准确性评估 MIXED-POR 和 PURE-SIG 的检出率。
总体而言,分析了 114 处病变。58 处(50.9%)为 MIXED-POR。活检时,MIXED-POR 的检出率明显低于 PURE-SIG(p<0.0001)。ME-NBI 检测到具有不规则血管的 MIXED-POR 明显多于 PURE-SIG(p<0.0001)。联合方法可以检测到更多的 MIXED-POR 比 PURE-SIG(p<0.0001)。与单独活检相比,联合方法诊断 MIXED-POR 的敏感性和准确性显著提高(p<0.0001)。
讨论/结论:联合活检和 ME-NBI 可提高 ESD 前未分化型癌症的术前诊断准确性。